EGFR Mutation Positive Stage IV Non-Small-Cell Lung Cancer: Treatment Beyond Progression

Non-small-cell lung cancer (NSCLC) is the leading cause of death from cancer for both men and women. Chemotherapy is the mainstay of treatment in advanced disease, but is only marginally effective. In about 30% of patients with advanced NSCLC in East Asia and in 10–15% in Western countries, epiderma...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Assche, Katrijn, Ferdinande, Liesbeth, Lievens, Yolande, Vandecasteele, Katrien, Surmont, Veerle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259002/
https://www.ncbi.nlm.nih.gov/pubmed/25538894
http://dx.doi.org/10.3389/fonc.2014.00350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259002/
https://www.ncbi.nlm.nih.gov/pubmed/25538894
http://dx.doi.org/10.3389/fonc.2014.00350

Ejemplares similares